Target intelligence / Profile preview

Enterovirus A71 Capsid Protein (None)

Target: None
Molecular classification: Viral structural protein

Overview

The Enterovirus A71 (EV-A71) capsid protein is the structural protein complex that forms the protective shell around the viral RNA genome. It is composed of four proteins: VP1, VP2, VP3, and VP4. VP1 is the most external and immunodominant protein, crucial for receptor binding and a key target for vaccine development. The capsid proteins mediate host cell attachment, facilitate endocytosis, and are essential for the uncoating of viral RNA upon entry into host cells.

Mechanism of action

Target of neutralizing antibodies

Biological functions

Genome encapsulation/protectionHost cell attachmentViral entryUncoatingImmune recognition

Disease associations

Hand, foot, and mouth disease (HFMD)Infection

Beyond the preview

Go deeper on Enterovirus A71 Capsid Protein (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterovirus A71 Capsid Protein (None).

Explore the full profile